# Study of LY3023414 for the Treatment of Recurrent or Persistent Endometrial Cancer

> **NCT02549989** · PHASE2 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 28 (actual)

## Conditions studied

- Endometrial Cancer
- Recurrent Endometrial Cancer

## Interventions

- **DRUG:** LY3023414

## Key facts

- **NCT ID:** NCT02549989
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2022-03-23
- **Final completion:** 2022-03-23
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2023-02-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02549989

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02549989, "Study of LY3023414 for the Treatment of Recurrent or Persistent Endometrial Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02549989. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*